Recently diagnosed rheumatoid arthritis patients benefit from a treat-to-target strategy: results from the DREAM registry.

Clin Rheumatol 2016 Mar 6;35(3):609-15. Epub 2016 Feb 6.

Arthritis Center Twente, Department of Rheumatology, Medisch Spectrum Twente, PO BOX 50 000, 7500 KA, Enschede, The Netherlands.

Despite considerable evidence on the efficacy and safety of early aggressive treat-to-target (T2T) strategies in early rheumatoid arthritis (RA), a proportion of patients still fail to reach remission. The goal of this study is to examine remission rates and predictors of remission in a real life T2T cohort of consecutive patients with a recent diagnosis of RA. Baseline demographics, clinical, laboratory and patient-reported variables and 1-year follow-up disease activity data were used from patients with early RA included in the DREAM remission induction cohort II study. Survival analyses and simple and multivariable logistic regression analyses were used to examine remission rates and significant predictors of achieving remission. A total of 137 recently diagnosed consecutive RA patients were available for this study. During the first year after inclusion, DAS28 remission was achieved at least once in 77.2 % of the patients and the median time to first remission was 17 weeks. None of the examined baseline variables were robustly associated with achieving remission within 1 year and in the multivariable analysis only lower ESR (pā€‰=ā€‰0.005) remained significantly associated with achieving fast remission within 17 weeks. During the first year of their disease a high proportion of recently diagnosed RA patient achieved remission, with only a small percentage of patients needing bDMARD therapy. Combined with the absence of baseline predictors of remission, this suggests that clinicians in daily clinical practice may focus on DAS28 scores only, without needing to take other patients characteristics into account.

Download full-text PDF

Source
http://doc.utwente.nl/99502/1/art%253A10.1007%252Fs10067-016
Web Search
http://link.springer.com/10.1007/s10067-016-3191-3
Publisher Site
http://dx.doi.org/10.1007/s10067-016-3191-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785198PMC
March 2016
4 Reads

Publication Analysis

Top Keywords

remission
12
rates predictors
8
examine remission
8
predictors remission
8
achieving remission
8
consecutive patients
8
remission weeks
8
remission rates
8
patients
8
rheumatoid arthritis
8
associated achieving
8
inclusion das28
4
year inclusion
4
patients study
4
examined baseline
4
study year
4
das28 remission
4
achieved 772
4
weeks examined
4
median time
4

References

(Supplied by CrossRef)

KE Donahue et al.
Ann Intern Med 2008

MHY Ma et al.
Rheumatology (Oxford) 2010

M Vermeer et al.
Arthritis Rheum 2011

M Vermeer et al.
Arthritis Care Res (Hoboken) 2013

E Gremese et al.
Ann Rheum Dis 2013

M Schoels et al.
Ann Rheum Dis 2010

JS Smolen et al.
Ann Rheum Dis 2010

L Gossec et al.
Ann Rheum Dis 2004

DL Scott et al.
Lancet 1987

RM Pope et al.
Am J Med 1996

TS Shaver et al.
J Rheumatol 2008

Similar Publications